- Parties: The plaintiffs were Knight Therapeutics Inc. and Currax Pharmaceuticals LLC. The defendant was Taro Pharmaceuticals Inc.

- Subject Matter: This action involved Knight Therapeutics Inc. and Currax Pharmaceuticals LLC alleging that Taro Pharmaceuticals Inc. infringed their pharmaceutical patent rights under the Patented Medicines (Notice of Compliance) Regulations. The plaintiffs claimed that the defendant’s activities relating to a drug product engaged their patented medicines and associated rights. This case is ongoing.

- Date: The hearing was set on March 27, 2026.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.